Argenx Se (ARGX) Change in Cash (2015 - 2023)

Argenx Se (ARGX) posted Change in Cash of $488.9 million for Q2 2023, up 364.22% on a QoQ basis from -$185.0 million in Q1 2023, and up 168.45% year-over-year from $182.1 million in Q2 2022.

Argenx Se (ARGX) Change in Cash (2015 - 2023) Analysis & Trends

Argenx Se's Change in Cash history runs 5 years deep, the most recent figure standing at $488.9 million for Q2 2023.

  • Quarterly Change in Cash rose 168.45% year-over-year to $488.9 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $19.2 million (up 104.64% YoY) and the FY2025 annual result came in at $1.9 billion, up 265.4% from the prior year.
  • Change in Cash was $488.9 million for Q2 2023 at Argenx Se, up from -$185.0 million in the prior quarter.
  • Across five years, Change in Cash topped out at $1.2 billion in Q3 2022 and bottomed at -$1.5 billion in Q4 2022.
  • A 4-year average of $80.1 million and a median of $105.2 million in 2020 frame the typical range for Change in Cash.
  • Annual changes were most pronounced in 2021 — Change in Cash plunged 992.91% — and 2022, when it surged 684.14%.
  • Argenx Se's Change in Cash stood at $58.8 million in 2020, then sank by 729.43% to -$370.1 million in 2021, then plunged by 298.12% to -$1.5 billion in 2022, then soared by 133.18% to $488.9 million in 2023.
  • Business Quant data shows ARGX's Change in Cash at $488.9 million in Q2 2023, -$185.0 million in Q1 2023, and -$1.5 billion in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -22.03 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -2.44 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 243.78 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 417.10 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -153.10 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 57.19 Mn
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn 53.61 Mn

Historic Data

Download Data
DateValue
Jun 30, 2023 488.90 Mn
Mar 31, 2023 -185.04 Mn
Dec 31, 2022 -1.47 Bn
Sep 30, 2022 1.19 Bn
Jun 30, 2022 -714.24 Mn
Mar 31, 2022 518.66 Mn
Dec 31, 2021 -370.06 Mn
Sep 30, 2021 151.58 Mn
Jun 30, 2021 -524.97 Mn
Mar 31, 2021 910.90 Mn
Jun 30, 2020 58.79 Mn
Mar 31, 2020 910.90 Mn
Dec 31, 2015 11.27 Bn